1352 related articles for article (PubMed ID: 33306235)
1. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
2. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis?
Sacchi MC; Tamiazzo S; Lauritano EC; Bonometti R
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11960-11963. PubMed ID: 33275270
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19.
Zhou Y; Han T; Chen J; Hou C; Hua L; He S; Guo Y; Zhang S; Wang Y; Yuan J; Zhao C; Zhang J; Jia Q; Zuo X; Li J; Wang L; Cao Q; Jia E
Clin Transl Sci; 2020 Nov; 13(6):1077-1086. PubMed ID: 32315487
[TBL] [Abstract][Full Text] [Related]
4. The intersection of COVID-19 and autoimmunity.
Knight JS; Caricchio R; Casanova JL; Combes AJ; Diamond B; Fox SE; Hanauer DA; James JA; Kanthi Y; Ladd V; Mehta P; Ring AM; Sanz I; Selmi C; Tracy RP; Utz PJ; Wagner CA; Wang JY; McCune WJ
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34710063
[TBL] [Abstract][Full Text] [Related]
5. Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications.
Dalakas MC; Bitzogli K; Alexopoulos H
Front Immunol; 2021; 12():627285. PubMed ID: 33679770
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2 infection and increasing autoimmune disorders among ICU-hospitalized COVID-19 patients.
Mosavat A; Mirhosseini A; Shariati A; Mohareri M; Valizadeh N; Mohammadi FS; Shamsian SAA; Jafari Rad M; Rezaee SA
Int J Rheum Dis; 2023 Nov; 26(11):2151-2156. PubMed ID: 37578135
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Fatone MC
Curr Rheumatol Rev; 2021; 17(1):7-16. PubMed ID: 33019935
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
Baiocchi GC; Vojdani A; Rosenberg AZ; Vojdani E; Halpert G; Ostrinski Y; Zyskind I; Filgueiras IS; Schimke LF; Marques AHC; Giil LM; Lavi YB; Silverberg JI; Zimmerman J; Hill DA; Thornton A; Kim M; De Vito R; Fonseca DLM; Plaça DR; Freire PP; Camara NOS; Calich VLG; Scheibenbogen C; Heidecke H; Lattin MT; Ochs HD; Riemekasten G; Amital H; Shoenfeld Y; Cabral-Marques O
J Med Virol; 2023 Feb; 95(2):e28538. PubMed ID: 36722456
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Systemic Sclerosis After Covid-19 Infection.
Fineschi S
Front Immunol; 2021; 12():686699. PubMed ID: 34262566
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19.
Lui DTW; Lee CH; Chow WS; Lee ACH; Tam AR; Fong CHY; Law CY; Leung EKH; To KKW; Tan KCB; Woo YC; Lam CW; Hung IFN; Lam KSL
J Clin Endocrinol Metab; 2021 Jan; 106(2):e926-e935. PubMed ID: 33141191
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and autoimmune diseases: is there a connection?
Votto M; Castagnoli R; Marseglia GL; Licari A; Brambilla I
Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):185-192. PubMed ID: 36728317
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and autoimmune diseases.
Liu Y; Sawalha AH; Lu Q
Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.
Taeschler P; Cervia C; Zurbuchen Y; Hasler S; Pou C; Tan Z; Adamo S; Raeber ME; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Brodin P; Nilsson J; Probst-Müller E; Boyman O
Allergy; 2022 Aug; 77(8):2415-2430. PubMed ID: 35364615
[TBL] [Abstract][Full Text] [Related]
16. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K
Front Immunol; 2020; 11():587517. PubMed ID: 33123171
[TBL] [Abstract][Full Text] [Related]
17. [SARS-CoV-2 infection and autoimmunity].
Meyer-Bahlburg A
Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
[TBL] [Abstract][Full Text] [Related]
18. The onset of
Sacchi MC; Pelazza C; Bertolotti M; Agatea L; De Gaspari P; Tamiazzo S; Ielo D; Stobbione P; Grappiolo M; Bolgeo T; Novel P; Ciriello MM; Maconi A
Autoimmunity; 2023 Dec; 56(1):2229072. PubMed ID: 37381619
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune complications of COVID-19.
Yazdanpanah N; Rezaei N
J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
